FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005
Lymphocytic Choriomeningitis Virus Infection in Organ Transplant Recipients-Massachusetts, Rhode Island, 2005
MMWR 54:537-539, , 2005
CT and MRI Findings of Intracranial Lymphoma
AJR 184:1679-1685, Slone,H.W.,et al, 2005
Clinicopath Conf,Encephalomyelitis Due to West Nile Virus and CLL, Case 22-2005
NEJM 353:287-295, Hollande,H.,et al, 2005
Pediatric Central Nervous System Posttransplant Lymphoproliferative Disorder
AJNR 26:1695-1697, Brennan,.C.,et al, 2005
Primary CNS Lymphoma in Myasthenic on Long-term Azathioprine
J NeuroOncol 74:91-92, Finelli,P.F., 2005
Primary CNS Lymphoma Complicating Treatment of Myasthenia Gravis with Mycophenolate Mofetil
Neurol 65:639-641, Vernino,S.,et al, 2005
Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005
Central Nervous System Lymphoma Associated with Mycophenolate Mofetil in Lupus Nephritis
Lupus 14:910-913, Dasgupta,N.,et al, 2005
Clinical Features and Diagnosis of Primary Central Nervous System Lymphoma
Hematol Oncol Clin North Am 19:689-703, Fitzsimmons,A.,et al, 2005
Infliximab and Reactivation of Cerebral Toxoplasmosis
NEJM 353:1530-1531, Callegari,P.E., 2005
Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Clin Inf Dis 41:634-653, Roden, M.M.,et al, 2005
Update on Susacs Syndrome
Curr Opin Neurol 18:311-314, Gross,M. &Eliashar,R., 2005
Clinical Manifestations of Cerebral Amyloid Angiopathy-Related Inflammation
Ann Neurol 55:250-256, Eng,J.A.,et al, 2004
Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004
Babesiosis and HIV
Lancet 363:704, Froberg,M.K.,et al, 2004
MR Imaging in Toxoplasmosis Encephalitis After Bone Marrow Transplantation: Paucity of Enhancement Despite Fulminant Disease
AJNR 25:270-273, Ionita,C.,et al, 2004
Treatment of Refractory Neurosarcoidosis with Cladribine
NEJM 350:1798-1799, Tikoo,R.K.,et al, 2004
Clinicopath Conf., Progessive Multifocal Leukoencephalopathy
NEJM 350:1884-1893, Case 14-2004, 2004
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Fatal Myositis Due to the Microsporidian Brachiola algerae, a Mosquito Pathogen
NEJM 351:42-47, Coyle,C.M.,et al, 2004
Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004
Naturally Acquired West Nile Virus Encephalomyelitis in Transplant Recipients
Arch Neurol 61:1210-1220, Kleinschmidt-DeMasters,B.K.,et al, 2004
Tacrolimus Leukoencephalopathy: A Neuropathologic Confirmation
Neurol 63:1132-1133, Lavigne,C.M.,et al, 2004
Cerebral Toxoplasmosis in a Patient with Common Variable Immunodeficiency
Neurol 63:2192-2193, Holtkamp,M.,et al, 2004
Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004
Treatment of Refractory Myasthenia: "Rebooting" with High-Dose Cyclophosphamide
Ann Neurol 53:29-34,7, Drachman,D.B.,et al, 2003
Bilateral Striatal Necrosis Associated with Mycoplasma pneumoniae Infection
NEJM 348:720, van Vuiren,M. &Uhl,M., 2003
Bilateral Vertebral Artery Occlusion Resulting from Giant Cell Arteritis: Report of 3 Cases and Review of the Literature
Medicine 82:1-12, Ruegg,S.,et al, 2003
Prospective Evaluation of Neurological Complications After Allogeneic Bone Marrow Transplantation
Neurol 60:842-848, Sostak,P.,et al, 2003
Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases
Arch Neurol 60:322-328, Wegner,D.A.,et al, 2003
West Nile Encephalitis
BMJ 326:865-869, Solomon,T.,et al, 2003
Transmission of West Nile Virus from an Organ Donor to Four Transplant Recipients
NEJM 348:2196-2203, Iwamoto,M.,et al, 2003
Lupus and Zoster
Lancet 362:616, Douglas,K.M.J., 2003
Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 61:736-740, Hughes,R.A.C.,et al, 2003
Prognosis of Patients with Suspected Primary CNS Angiitis and Negative Brain Biopsy
Neurol 61:831-833, Alreshaid,A.A.&Powers,W.J., 2003
Polymyositis and Dermatomyositis
Lancet 362:971-982, Dalakas,M.C.&Hohlfeld,R., 2003
Voltage-Gated Potassium Channel Antibodies in Limbic Encephalitis
Ann Neurol 54:530-533, Pozo-Rosich,P.,et al, 2003
Severe Tacrolimus Leukoencephalopathy After Liver Transplantation
AJNR 24:2085-2088, Schuuring,J.,et al, 2003
Treatment of Autoimmune Myasthenia Gravis
Neurol 61:1652-1661, Richman,D.P. & Agius,M.A., 2003
Glioblastoma in Kidney Transplant Recipients. Report of Five Cases
J Neurooncol 63:33-37, Salvati,M.,et al, 2003
Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003
Serial Proton MR Spectroscopy and Diffusion Imaging Findings in HIV-Related Herpes Simplex Encephalitis
AJNR 24:2015-2019, S�mann,P.G., et al, 2003
Cerebral Toxoplasmosis Following Etanercept Treatment for Idiophatic Pneumonia Syndrome after Autologous Peripheral Blood Progenitor Cell Transplantation (PBPCT)
Ann Hematol 82:649-653, Gonzalez-Vicent, M.,et al, 2003
Polymyalgia Rheumatica and Giant-Cell Arteritis
NEJM 347:261-271, Salvarani,C.,et al, 2002
Severe Neurologic Complications After Hematopoietic Stem Cell Transplantation in Children
Neurol 59:1895-1904,E13, Farci,M.,et al, 2002
Steroid Treatment for Myasthenia Gravis
Muscle Nerve 25:115-121, Rivner,M.H., 2002
An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002
Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002